LAINGAX
Dead / Abandoned — Abandoned — no statement of use filed (as of 12 Jul 2021)
What this means for you
This application is over — abandoned 12 Jul 2021. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 87693311
- Mark type
- Stylized text
- Filed
- 21 Nov 2017
- Published for opposition
- 10 Apr 2018
- Abandoned
- 12 Jul 2021
- Attorney of record
- GABRIELLE S. ROTH
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical preparations for use in stimulating white blood cell production and pharmaceutical preparations for the treatment of cancer and of blood disorders and conditions, including those caused by cancer treatments
Owner
- Tanvex BioPharma, Inc., KYI-1205, KY
- Tanvex BioPharma, Inc., KYI-1205, KY
Prosecution history
- 12 Jul 2021 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 12 Jul 2021 — ABANDONMENT - NO USE STATEMENT FILED
- 10 Dec 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Dec 2020 — SOU EXTENSION 5 GRANTED
- 12 Nov 2020 — SOU EXTENSION 5 FILED
- 23 Nov 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 12 Nov 2020 — SOU TEAS EXTENSION RECEIVED
- 13 May 2020 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 May 2020 — SOU EXTENSION 4 GRANTED
- 11 May 2020 — SOU EXTENSION 4 FILED
- 11 May 2020 — SOU TEAS EXTENSION RECEIVED
- 08 Nov 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 06 Nov 2019 — SOU EXTENSION 3 GRANTED
- 06 Nov 2019 — SOU EXTENSION 3 FILED
- 06 Nov 2019 — SOU TEAS EXTENSION RECEIVED